Annual Reports in Medicinal Chemistry - 1st Edition - ISBN: 9780120405398, 9780080471976

Annual Reports in Medicinal Chemistry, Volume 39

1st Edition

Editors: Annette Doherty
Paperback ISBN: 9780120405398
eBook ISBN: 9780080471976
Imprint: Academic Press
Published Date: 15th December 2004
Page Count: 448
Tax/VAT will be calculated at check-out
161.00
110.00
137.00
185.00
Unavailable
Compatible Not compatible
VitalSource PC, Mac, iPhone & iPad Amazon Kindle eReader
ePub & PDF Apple & PC desktop. Mobile devices (Apple & Android) Amazon Kindle eReader
Mobi Amazon Kindle eReader Anything else

Institutional Access


Table of Contents

I. CENTRAL NERVOUS SYSTEM DISEASES

  1. Attention Deficit Hyperactivity Disorder: Pathophysiology and Design of New Treatments (S.A. Glase, D.J. Dooley).
  2. Ionotropic GABA Receptors as Therapeutic Targets for Memory and Sleep Disorders (M. Chebib et al.).
  3. Melatonin Agonists for the Treatment of Sleep Disorders and Major Depression (L.R. Fitzgerald, J.E. Reed).

II. CARDIOVASCULAR AND METABOLIC DISEASES

  1. Recent Advances in Therapeutic Approaches to Type 2 Diabetes (Ramakanth Sarabu, J. Tilley).
  2. Recent Progress in Histamine H3 Receptor Chemistry (R. Aslanian, Neng-Yang Shih).
  3. Anti-Resorptive and Anabolic Bone Agents (G.D. Hartman, R.S. Meissner).
  4. Inhibition of the Cysteine Protease Cathepsin-K (EC 3.4.22.38)(R.W. Marquis).
  5. Nonpeptide Gonadotropin Releasing Hormone Antagonists (Yun-Fei Zhu et al.).

III. INFLAMMATORY, PULMONARY, AND GASTROINTESTINAL DISEASES

  1. Bradykinin B2 Antagonists for the Treatment of Pain (E.K. Dziadulewicz).
  2. Selective Cyclooyxgenase-2 Inhibitors (W. Cameron Black).
  3. The Discovery of Small Molecule C5a Antagonists (A.J. Hutchison, J.E. Krause).
  4. CCR1 Antagonists (K.G. Carson et al.).

IV. CANCER AND INFECTIOUS DISEASES

  1. Recent Advances in Antimetabolite Cancer Chemotherapies (J.R. Henry, M.M. Mader).
  2. Mitotic Kinesin Inhibitors as Novel Anticancer Agents (K.W. Wood, G. Bergnes).
  3. Recent Advances in Medicinal Chemistry of Histone Deacetylase Inhibitors (H. Weinmann, E. Ottow).
  4. Therapeutic Opportunities for the Treatment of Biofilm-Associated Infections (Zhenkun Ma et al.).
  5. Biowarfare Pathogens. Is the Research Flavor Different Than That of Clinically Relevant Pathogens? (Ving J. Lee).
  6. HCV Antiviral Agents (R.C. Griffith et al.).

V. TOPICS IN BIOLOGY

  1. Pleiotropic Effects of Statins (A. Floto et al.).
  2. Comparative Protein Structure Modeling and Its Applications to Drug Discovery (M. Jacobson, A. Sali).

VI. TOPICS IN DRUG DESIGN AND DISCOVERY

  1. Drug Transporters and Their Role in Tissue Distribution (A.H. Dantzig).
  2. The Hit-to-Lead Process in Drug Discovery (P. Gillespie, R.A. Goodnow, Jr.).
  3. Prodrug Strategies in the Design of Nucleoside and Nucleotide Antiviral Therapeutics (R.L Mackman, T. Cihlar).
  4. Pre-Clinical Assessment of Drug-Induced QT Interval Prolongation. Current Issues and Impact on Drug Discovery (B. Fermini, A.A. Fossa).

VII. TRENDS AND PERSPECTIVES

  1. To Market, To Market-2003 (Shridhar Hegde, J. Carter).

Description

I. CENTRAL NERVOUS SYSTEM DISEASES

  1. Attention Deficit Hyperactivity Disorder: Pathophysiology and Design of New Treatments (S.A. Glase, D.J. Dooley).
  2. Ionotropic GABA Receptors as Therapeutic Targets for Memory and Sleep Disorders (M. Chebib et al.).
  3. Melatonin Agonists for the Treatment of Sleep Disorders and Major Depression (L.R. Fitzgerald, J.E. Reed).

II. CARDIOVASCULAR AND METABOLIC DISEASES

  1. Recent Advances in Therapeutic Approaches to Type 2 Diabetes (Ramakanth Sarabu, J. Tilley).
  2. Recent Progress in Histamine H3 Receptor Chemistry (R. Aslanian, Neng-Yang Shih).
  3. Anti-Resorptive and Anabolic Bone Agents (G.D. Hartman, R.S. Meissner).
  4. Inhibition of the Cysteine Protease Cathepsin-K (EC 3.4.22.38)(R.W. Marquis).
  5. Nonpeptide Gonadotropin Releasing Hormone Antagonists (Yun-Fei Zhu et al.).

III. INFLAMMATORY, PULMONARY, AND GASTROINTESTINAL DISEASES

  1. Bradykinin B2 Antagonists for the Treatment of Pain (E.K. Dziadulewicz).
  2. Selective Cyclooyxgenase-2 Inhibitors (W. Cameron Black).
  3. The Discovery of Small Molecule C5a Antagonists (A.J. Hutchison, J.E. Krause).
  4. CCR1 Antagonists (K.G. Carson et al.).

IV. CANCER AND INFECTIOUS DISEASES

  1. Recent Advances in Antimetabolite Cancer Chemotherapies (J.R. Henry, M.M. Mader).
  2. Mitotic Kinesin Inhibitors as Novel Anticancer Agents (K.W. Wood, G. Bergnes).
  3. Recent Advances in Medicinal Chemistry of Histone Deacetylase Inhibitors (H. Weinmann, E. Ottow).
  4. Therapeutic Opportunities for the Treatment of Biofilm-Associated Infections (Zhenkun Ma et al.).
  5. Biowarfare Pathogens. Is the Research Flavor Different Than That of Clinically Relevant Pathogens? (Ving J. Lee).
  6. HCV Antiviral Agents (R.C. Griffith et al.).

V. TOPICS IN BIOLOGY

  1. Pleiotropic Effects of Statins (A. Floto et al.).
  2. Comparative Protein Structure Modeling and Its Applications to Drug Discovery (M. Jacobson, A. Sali).

VI. TOPICS IN DRUG DESIGN AND DISCOVERY

  1. Drug Transporters and Their Role in Tissue Distribution (A.H. Dantzig).
  2. The Hit-to-Lead Process in Drug Discovery (P. Gillespie, R.A. Goodnow, Jr.).
  3. Prodrug Strategies in the Design of Nucleoside and Nucleotide Antiviral Therapeutics (R.L Mackman, T. Cihlar).
  4. Pre-Clinical Assessment of Drug-Induced QT Interval Prolongation. Current Issues and Impact on Drug Discovery (B. Fermini, A.A. Fossa).

VII. TRENDS AND PERSPECTIVES

  1. To Market, To Market-2003 (Shridhar Hegde, J. Carter).

Key Features

  • Annual comprehensive reviews of the past year literature in many topics of interest to medicinal chemists
  • Includes a comprehensive set of indices to easily locate topics in Volumes 1-38 of this series
  • Provides critical review on hot topics in medicinal chemistry

Readership

For medicinal, pharmaceutical and organic chemists.


Details

No. of pages:
448
Language:
English
Copyright:
© Academic Press 2005
Published:
Imprint:
Academic Press
eBook ISBN:
9780080471976
Paperback ISBN:
9780120405398

About the Editors

Annette Doherty Editor

Affiliations and Expertise

Pfizer Global R&D, Sandwich Laboratories, United Kingdom